par Syn, Nicholas Li Xun;Wee, Ian;Wong, Andrea Li Ann;Goh, Robby R.M.;Ow, Samuel Guan Wei;Lambertini, Matteo ;Lee, Soo Chin
Référence Cochrane database of systematic reviews, 2018, 1, CD012919
Publication Publié, 2018-01
Référence Cochrane database of systematic reviews, 2018, 1, CD012919
Publication Publié, 2018-01
Article révisé par les pairs
Résumé : | This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the effects of cyclin-dependent kinase (CDK) 4/6 inhibitors in the treatment of patients with hormone receptor-positive advanced breast cancer. |